GlassScriptPhysician profile
Torri M Janecek
NPI 1124200308
$2,467.58
in general payments reported to CMS, 2019-2025
29 companies · $559 in 2025
The $559 reported for 2025 was more than what 83% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $192 · 2020: $153 · 2021: $107 · 2022: $348 · 2023: $484 · 2024: $624 · 2025: $559.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,667.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,667.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $698.30 | 2023-2025 | Veozah, Myrbetriq |
| Abbvie INC. | $395.58 | 2019-2023 | |
| Sumitomo Pharma America, INC. | $194.53 | 2023-2025 | Myfembree, Gemtesa |
| Bayer Healthcare Pharmaceuticals INC. | $146.60 | 2019-2023 | |
| Exeltis, USA INC. | $124.34 | 2021-2025 | Slynd |
| Intuitive Surgical, INC. | $112.89 | 2023 | Da Vinci Surgical System |
| Organon LLC | $90.44 | 2023-2025 | Nexplanon, Jada System |
| Biogen, INC. | $72.76 | 2024-2025 | Zurzuvae |
| Daiichi Sankyo INC. | $67.20 | 2022-2023 | Injectafer |
| Hologic Sales and Service, LLC | $64.34 | 2019-2025 | Novasure, Acessa Provu System, Coolseal Generator |
| Octapharma USA, INC. | $62.37 | 2025 | Fibryga |
| Merck Sharp & Dohme LLC | $53.38 | 2020-2024 | Gardasil 9, Capvaxive, Gardasil |
| Myovant Sciences INC. | $46.35 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $45.96 | 2022 | |
| Coopersurgical, INC. | $35.57 | 2023-2025 | Paragard T 380a, Paragard T 380a |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $30.11 | 2020-2021 | |
| Pfizer INC. | $25.41 | 2021-2022 | |
| Allergan, INC. | $24.71 | 2019-2020 | |
| Gynesonics, INC. | $21.11 | 2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Vertical Pharmaceuticals, LLC | $18.78 | 2020 | |
| Baxter Healthcare | $17.51 | 2022 | |
| Novo Nordisk INC | $17.12 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $16.65 | 2025 | Exparel |
| Medtronic, INC. | $15.54 | 2022 | |
| Lilly USA, LLC | $15.43 | 2025 | Zepbound |
| Scynexis, INC. | $15.31 | 2022 | |
| Amgen INC. | $14.38 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $13.15 | 2021 | |
| Lupin INC. | $11.76 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Torri Janecek listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.